The/DT/O 200,000/CD/O shares/NNS/O are/VBP/O about/RB/O 23/CD/O %/NN/O of/IN/O Interferon/NNP/B-ORG 's/POS/O common/JJ/O shares/NNS/O outstanding/JJ/O ,/,/O excluding/VBG/O National/NNP/B-ORG Patent/NNP/I-ORG 's/POS/I-ORG stake/NN/O ././O
Noting/VBG/O the/DT/O recent/JJ/O Food/NNP/B-ORG and/CC/I-ORG Drug/NNP/I-ORG Administration/NNP/I-ORG approval/NN/O of/IN/O Interferon/NNP/B-ORG 's/POS/O genital/JJ/O warts/NNS/O treatment/NN/O ,/,/O National/NNP/B-ORG Patent/NNP/I-ORG said/VBD/O it/PRP/O believes/VBZ/O Interferon/NNP/B-ORG 's/POS/O stock/NN/O is/VBZ/O undervalued/JJ/O ././O
